| Ident. | Authors (with country if any) | Title |
|---|
| 000134 (2021) |
Fatemeh Roozbeh [Iran] ; Majid Saeedi [Iran] ; Reza Alizadeh-Navaei [Iran] ; Akbar Hedayatizadeh-Omran [Iran] ; Shahin Merat [Iran] ; Hannah Wentzel [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Amir Shamshirian [Iran] | Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial. |
| 000424 (2021) |
Petri J. Vainio [Finlande] ; Pauliina Hietasalo [Finlande] ; Anna-Liisa Koivisto [Finlande] ; Susanna K Ri Inen [Finlande] ; Jari Turunen [Finlande] ; Mika Virtala [Finlande] ; Jouni Vuorinen [Finlande] ; Mika Scheinin [Finlande] | Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. |
| 000444 (2021) |
Ruanne V. Barnabas ; Elizabeth R. Brown ; Anna Bershteyn ; Helen C. Stankiewicz Karita [États-Unis] ; Christine Johnston ; Lorna E. Thorpe ; Angelica Kottkamp ; Kathleen M. Neuzil ; Miriam K. Laufer ; Meagan Deming ; Michael K. Paasche-Orlow ; Patricia J. Kissinger ; Alfred Luk ; Kristopher Paolino ; Raphael J. Landovitz ; Risa Hoffman ; Torin T. Schaafsma [États-Unis] ; Meighan L. Krows [États-Unis] ; Katherine K. Thomas [États-Unis] ; Susan Morrison [États-Unis] ; Harald S. Haugen [États-Unis] ; Lara Kidoguchi [États-Unis] ; Mark Wener [États-Unis] ; Alexander L. Greninger ; Meei-Li Huang ; Keith R. Jerome ; Anna Wald ; Connie Celum [États-Unis] ; Helen Y. Chu [États-Unis] ; Jared M. Baeten [États-Unis] | Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. |
| 000524 (2021) |
Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran] | Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. |
| 000525 (2021) |
Benjamin S. Abella [États-Unis] ; Eliana L. Jolkovsky [États-Unis] ; Barbara T. Biney [États-Unis] ; Julie E. Uspal [États-Unis] ; Matthew C. Hyman [États-Unis] ; Ian Frank [États-Unis] ; Scott E. Hensley [États-Unis] ; Saar Gill [États-Unis] ; Dan T. Vogl [États-Unis] ; Ivan Maillard [États-Unis] ; Daria V. Babushok [États-Unis] ; Alexander C. Huang [États-Unis] ; Sunita D. Nasta [États-Unis] ; Jennifer C. Walsh [États-Unis] ; E Paul Wiletyo [États-Unis] ; Phyllis A. Gimotty [États-Unis] ; Michael C. Milone [États-Unis] ; Ravi K. Amaravadi [États-Unis] | Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. |
| 000789 (2021) |
Oriol Mitjà ; Marc Corbacho-Monné ; Maria Ubals ; Andrea Alemany ; Clara Su Er ; Cristian Tebé ; Aurelio Tobias ; Judith Pe Afiel ; Ester Ballana ; Carla A. Pérez ; Pol Admella ; Núria Riera-Martí ; Pep Laporte ; Jordi Mitjà ; Mireia Clua ; Laia Bertran ; Maria Sarquella ; Sergi Gavilán ; Jordi Ara ; Josep M. Argimon ; Gabriel Cuatrecasas ; Paz Ca Adas ; Aleix Elizalde-Torrent ; Robert Fabregat ; Magí Farré ; Anna Forcada ; Gemma Flores-Mateo ; Cristina L Pez ; Esteve Muntada ; Núria Nadal ; Silvia Narejos ; Aroa Nieto ; Nuria Prat ; Jordi Puig ; Carles Qui Ones ; Ferran Ramírez-Viaplana ; Juliana Reyes-Urue A ; Eva Riveira-Mu Oz ; Lidia Ruiz ; Sergi Sanz ; Alexis Sentís ; Alba Sierra ; César Velasco ; Rosa M. Vivanco-Hidalgo ; Juani Zamora ; Jordi Casabona ; Martí Vall-Mayans ; Camila González-Beiras ; Bonaventura Clotet | A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. |
| 000B00 (2020) |
Giovanni Di Perri [Italie] | The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection |
| 000B59 (2020) |
Siri Göpel [Allemagne] ; Wolfgang Bethge [Allemagne] ; Peter Martus [Allemagne] ; Florian Kreth [Allemagne] ; Thomas Iftner [Allemagne] ; Stefanie Joos [Allemagne] ; Stefanie Döbele [Allemagne] ; Benjamin Mordmüller [Allemagne] ; Peter Kremsner [Allemagne] ; Thomas Ettrich [Allemagne] ; Thomas Seufferlein [Allemagne] ; Michael Bitzer [Allemagne] ; Nisar Malek [Allemagne] | Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. |
| 000C43 (2020) |
Ashkan Emadi [États-Unis] ; Joel V. Chua [États-Unis] ; Rohit Talwani [États-Unis] ; S Ren M. Bentzen [États-Unis] ; John Baddley [États-Unis] | Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. |
| 000E10 (2020) |
Pradeesh Sivapalan [Danemark] ; Charlotte Suppli Ulrik [Danemark] ; Therese Sophie Lappere [Danemark] ; Josefin Viktoria Eklöf [Danemark] ; Saher Burhan Shaker [Danemark] ; Uffe Christian Steinholtz B Dtger [Danemark] ; Andrea Browatzki [Danemark] ; Christian Niels Meyer [Danemark] ; Ulla M Ller Weinreich [Danemark] ; Christian B. Laursen [Danemark] ; Tor Biering-S Rensen [Danemark] ; Filip Krag Knop [Danemark] ; Jens D. Lundgren [Danemark] ; Jens-Ulrik St Hr Jensen [Danemark] | Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. |
| 000E11 (2020) |
Pradeesh Sivapalan [Danemark] ; Charlotte Suppli Ulrik [Danemark] ; Rasmus Dahlin Bojesen [Danemark] ; Therese Sophie Lapperre [Danemark] ; Josefin Viktoria Eklöf [Danemark] ; Kjell Erik Julius H Kansson [Danemark] ; Andrea Browatzki [Danemark] ; Casper Tidemansen [Danemark] ; Jon Torgny Wilcke [Danemark] ; Julie Janner [Danemark] ; Vibeke Gottlieb [Danemark] ; Howraman Meteran [Danemark] ; Celeste Porsbjerg [Danemark] ; Birgitte Lindegaard Madsen [Danemark] ; Mia Moberg [Danemark] ; Lars Pedersen [Danemark] ; Thomas Lars Benfield [Danemark] ; Jens Dilling Lundgren [Danemark] ; Filip Krag Knop [Danemark] ; Tor Biering-S Rensen [Danemark] ; Muzhda Ghanizada [Danemark] ; Tine Peick Sonne [Danemark] ; Uffe Christian Steinholtz B Dtger [Danemark] ; Sidse Graff Jensen [Danemark] ; Daniel Bech Rasmussen [Danemark] ; Eva Br Ndum [Danemark] ; Oliver Djurhuus Tupper [Danemark] ; Susanne Wiemann S Rensen [Danemark] ; Gitte Alstrup [Danemark] ; Christian Borbjerg Laursen [Danemark] ; Ulla Weinrich M Ller [Danemark] ; Asger Sverrild [Danemark] ; Jens-Ulrik St Hr Jensen [Danemark] | Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. |
| 000E27 (2020) |
Berta Grau-Pujol [Espagne, Mozambique] ; Daniel Camprubí [Espagne] ; Helena Marti-Soler [Espagne] ; Marc Fernández-Pardos [Espagne] ; Caterina Guinovart [Espagne] ; Jose Mu Oz [Espagne] | Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. |
| 000E44 (2020) |
Sylvain A. Lother [Canada] ; Mahsa Abassi [États-Unis] ; Alyssa Agostinis [Canada, Irlande (pays)] ; Ananta S. Bangdiwala [États-Unis] ; Matthew P. Cheng [Canada] ; Glen Drobot [Canada] ; Nicole Engen [États-Unis] ; Kathy H. Hullsiek [États-Unis] ; Lauren E. Kelly [Canada] ; Todd C. Lee [Canada] ; Sarah M. Lofgren [États-Unis] ; Lauren J. Mackenzie [Canada] ; Nicole Marten [Canada] ; Emily G. Mcdonald [Canada] ; Elizabeth C. Okafor [États-Unis] ; Katelyn A. Pastick [États-Unis] ; Matthew F. Pullen [États-Unis] ; Radha Rajasingham [États-Unis] ; Ilan Schwartz [Canada] ; Caleb P. Skipper [États-Unis] ; Alexis F. Turgeon [Canada] ; Ryan Zarychanski [Canada] ; David R. Boulware [États-Unis] | Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. |
| 001023 (2020) |
Julio Vallejos [Argentine] ; Rodrigo Zoni [Argentine] ; Maria Bangher [Argentine] ; Silvina Villamandos [Argentine] ; Angelina Bobadilla [Argentine] ; Fabian Plano [Argentine] ; Claudia Campias [Argentine] ; Evangelina Chaparro Campias [Argentine] ; Fernando Achinelli [Argentine] ; Hector A. Guglielmone [Argentine] ; Jorge Ojeda [Argentine] ; Fernanda Medina [Argentine] ; Diego Farizano Salazar [Argentine] ; Gerardo Andino [Argentine] ; Natalia E. Ruiz Diaz [Argentine] ; Pablo Kawerin [Argentine] ; Elba Meza [Argentine] ; Silvana Dellamea [Argentine] ; Antonia Aquino [Argentine] ; Victor Flores [Argentine] ; Carolina N. Martemucci [Argentine] ; María Mercedes Vernengo [Argentine] ; Silvina María Martinez [Argentine] ; Juan Emanuel Segovia [Argentine] ; María Gabriela Aguirre [Argentine] | Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial. |
| 001171 (2020) |
Caleb P. Skipper ; Katelyn A. Pastick ; Nicole W. Engen ; Ananta S. Bangdiwala ; Mahsa Abassi ; Sarah M. Lofgren ; Darlisha A. Williams ; Elizabeth C. Okafor ; Matthew F. Pullen ; Melanie R. Nicol ; Alanna A. Nascene ; Kathy H. Hullsiek ; Matthew P. Cheng ; Darlette Luke ; Sylvain A. Lother [Canada] ; Lauren J. Mackenzie [Canada] ; Glen Drobot [Canada] ; Lauren E. Kelly [Canada] ; Ilan S. Schwartz [Canada] ; Ryan Zarychanski [Canada] ; Emily G. Mcdonald ; Todd C. Lee ; Radha Rajasingham ; David R. Boulware | Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. |
| 001184 (2020) |
Madunil A. Niriella [Sri Lanka] ; Dileepa S. Ediriweera [Sri Lanka] ; Arjuna P. De Silva [Sri Lanka] ; Ranjan Premarathne [Sri Lanka] ; Priyantha Balasooriya [Sri Lanka] ; Kaluthanthri D. Duminda [Sri Lanka] ; Neelika G. Malavige [Sri Lanka] ; Kamani Wanigasuriya [Sri Lanka] ; Sarath Lekamwasam [Sri Lanka] ; Senanayake A. Kularathne [Sri Lanka] ; Sisira Siribaddana [Sri Lanka] ; Hithanadura J. De Silva [Sri Lanka] ; Saroj Jayasinghe [Sri Lanka] | Hydroxychloroquine for post-exposure prophylaxis of COVID-19 among naval personnel in Sri Lanka: study protocol for a randomized, controlled trial. |
| 001195 (2020) |
Raquel González [Espagne, Mozambique] ; Laura García-Otero [Espagne, Mozambique] ; Clara Pons-Duran [Espagne] ; Elena Marbán-Castro [Espagne] ; Anna Goncé [Espagne] ; Elisa Llurba [Espagne] ; Maria Del Mar Gil [Espagne] ; Miguel Ngel Rodríguez-Zambrano [Espagne] ; Haily Chen [Espagne] ; Máximo Ramírez [Espagne] ; Azucena Bardají [Espagne, Mozambique] ; Clara Menendez [Espagne, Mozambique] | Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial. |
| 001367 (2020) |
Reihaneh Pirjani [Iran] ; Tahereh Soori [Iran] ; Ahmad Reza Dehpour [Iran] ; Mahdi Sepidarkish [Iran] ; Ashraf Moini [Iran] ; Arshia Shizarpour [Iran] ; Razieh Mohammad Jafari [Iran] | Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial. |
| 001509 (2020) |
Antonio Cuadrado-Lavín [Espagne] ; José Manuel Olmos [Espagne] ; José Manuel Cifrian [Espagne] ; Teresa Gimenez [Espagne] ; Marco Antonio Gandarillas [Espagne] ; Mar García-Saiz [Espagne] ; Maria Henar Rebollo [Espagne] ; Victor Martínez-Taboada [Espagne] ; Marcos L Pez-Hoyos [Espagne] ; María Carmen Fari As [Espagne] ; Javier Crespo [Espagne] | Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. |
| 001647 (2020) |
Christopher W. Jones [États-Unis] ; Ashley L. Woodford [États-Unis] ; Timothy F. Platts-Mills [États-Unis] | Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis. |
| 001855 (2020) |
František Duška [République tchèque] ; Petr Waldauf [République tchèque] ; Milada Hala Ová [République tchèque] ; Václav Zvoní Ek [République tchèque] ; Jakub Bala [République tchèque] ; Martin Balík [République tchèque] ; Jan Beneš [République tchèque] ; Olga Klementová [République tchèque] ; Irena Kozáková [République tchèque] ; Viktor Kubricht [République tchèque] ; Anne Le Roy [République tchèque] ; Tomáš Vymazal [République tchèque] ; Veronika Eho Ová [République tchèque] ; Vladimír Ern [République tchèque] | Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU. |
